Antithrombotic agents in coronary artery disease.

Suppr

超能文献

作者信息

Resnekov L, Chediak J, Hirsh J, Lewis H D

机构信息

University of Chicago Medical Center 60637.

出版信息

Chest. 1989 Feb;95(2 Suppl):52S-72S. doi: 10.1378/chest.95.2_supplement.52s.

DOI:10.1378/chest.95.2_supplement.52s

PMID:2644104

Abstract

摘要

相似文献

Antithrombotic agents in coronary artery disease.

Chest. 1989 Feb;95(2 Suppl):52S-72S. doi: 10.1378/chest.95.2_supplement.52s.

Antithrombotic agents in coronary artery disease.

Chest. 1998 Nov;114(5 Suppl):611S-633S. doi: 10.1378/chest.114.5_supplement.611s.

Unstable coronary artery disease: need for long-term antithrombotic treatment? Aspirin alone may not be the ideal antithrombotic strategy, but that's what we have adequate trial data for.

Cardiovasc Res. 1997 Feb;33(2):295-6. doi: 10.1016/s0008-6363(96)00244-1.

Unstable coronary artery disease--need for long-term antithrombotic treatment. Aspirin alone is not sufficient, I would associate an anticoagulant.

Cardiovasc Res. 1997 Feb;33(2):292-4. doi: 10.1016/s0008-6363(96)00243-x.

ABC of antithrombotic therapy: Antithrombotic therapy in myocardial infarction and stable angina.

BMJ. 2002 Nov 30;325(7375):1287-9. doi: 10.1136/bmj.325.7375.1287.

The current role of platelet-active drugs in ischaemic heart disease.

Drugs. 1991 May;41(5):665-71. doi: 10.2165/00003495-199141050-00001.

Low-molecular-weight heparin during instability in coronary artery disease, Fragmin during Instability in Coronary Artery Disease (FRISC) study group.

Lancet. 1996 Mar 2;347(9001):561-8.

[Long term aspirin in stable coronary disease with an indication for anticoagulation: is it reasonable?].

Rev Med Suisse. 2015 Oct 14;11(490):1904, 1906-8.

[Anticoagulants and antiaggregants in ischemic heart disease].

G Ital Cardiol. 1990 Aug;20(8):746-57.

Current practice in the use of anticoagulants for ischemic heart disease: a survey of 200 hospitals.

Heart Lung. 1976 Sep-Oct;5(5):742-6.

引用本文的文献

Research progress and strategy of FGF21 for skin wound healing.

Front Med (Lausanne). 2025 Mar 31;12:1510691. doi: 10.3389/fmed.2025.1510691. eCollection 2025.

Fabrication and Characterization of a Magnetic Drilling Actuator for Navigation in a Three-dimensional Phantom Vascular Network.

Sci Rep. 2018 Feb 27;8(1):3691. doi: 10.1038/s41598-018-22110-5.

Outcomes research in the development and evaluation of practice guidelines.

BMC Health Serv Res. 2002 Mar 25;2(1):7. doi: 10.1186/1472-6963-2-7.

Antiplatelet therapy--Part I.

West J Med. 1993 Apr;158(4):385-92.

Optimal treatment after acute myocardial infarction in the elderly.

Drugs Aging. 1995 Mar;6(3):181-91. doi: 10.2165/00002512-199506030-00002.

Common causes of cardiac emboli--left ventricular thrombi and atrial fibrillation.

West J Med. 1989 Aug;151(2):172-9.

Therapeutic priorities of Canadian internists.

CMAJ. 1990 Feb 15;142(4):329-33.

Guidelines on oral anticoagulation: second edition. British Society for Haematology. British Committee for Standards in Haematology. Haemostasis and Thrombosis Task Force.

J Clin Pathol. 1990 Mar;43(3):177-83. doi: 10.1136/jcp.43.3.177.

Risk-benefit assessment of anticoagulant therapy.

Drug Saf. 1991 Jan-Feb;6(1):54-69. doi: 10.2165/00002018-199106010-00006.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验